Restorative Therapies

Executive Summary

Restorative Therapies is a US-based medical device company specializing in integrated Functional Electrical Stimulation (FES) therapy systems for neurological recovery. Founded in 2003 and headquartered in Baltimore, the company focuses on conditions such as spinal cord injury, stroke, and multiple sclerosis. Its activity-based technology is designed for both clinical and home use, aiming to help patients achieve their full recovery potential. Despite operating for over two decades, Restorative Therapies remains a private entity with limited public financial or pipeline disclosures. The company competes in the growing neurorehabilitation market, which is driven by an aging population and increasing incidence of neurological disorders. Its existing product portfolio and established presence suggest a stable but potentially under-recognized position in the sector. However, without recent funding rounds or revenue data, assessing its near-term growth trajectory is challenging. The company's ability to expand market share will depend on technological differentiation, regulatory clearances, and adoption by rehabilitation centers.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) Clearance for Next-Generation FES System70% success
• Q4 2026Strategic Partnership with Major Rehabilitation Hospital Network50% success
• Q3 2026Publication of Positive Clinical Trial Results in Stroke Rehabilitation60% success